Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer

doi:10.3748/wjg.v27.i36.6093

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 36

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6096)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-11) series, Tables (1-4) series.

Item

Count

PDF

455

WORD

176

HTML

3686

Figures (1-11)

159

Tables (1-4)

149

Sum=4625

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

632

Download

839

Sum=1471

Sep 28, 2021 (publication date) through May 7, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Gastroenterol. Sep 28, 2021; 27(36): 6093-6109
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6093

Full Size Figure Download Figure

Figure 2 Analysis of tumor biological marker (carbohydrate antigen 19-9, tissue polypeptide specific antigen, carcinoembryonic antigen, vascular endothelial growth factor-A, and epidermal growth factor receptor) in the serum of pancreatic cancer patients. PC: Pancreatic cancer; CA19-9: Carbohydrate antigen 19-9; TPS: Tissue polypeptide specific antigen; CEA: Carcinoembryonic antigen; VEGF-A: Vascular endothelial growth factor-A; EGFR: Epidermal growth factor receptor.

Citation: Rah B, Banday MA, Bhat GR, Shah OJ, Jeelani H, Kawoosa F, Yousuf T, Afroze D. Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer. World J Gastroenterol 2021; 27(36): 6093-6109
URL: https://www.wjgnet.com/1007-9327/full/v27/i36/6093.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i36.6093